Navigation Links
CuraGen Reports Third Quarter 2007 Financial Results
Date:10/25/2007

BRANFORD, Conn., Oct. 25 /PRNewswire-FirstCall/ -- CuraGen Corporation (Nasdaq: CRGN), a clinical-stage biopharmaceutical company focused on oncology, today reported its financial results for the third quarter of 2007. For the quarter ended September 30, 2007, CuraGen reported a net loss of $9.9 million, or $0.18 per share, compared to a consolidated net loss of $15.9 million, or $0.29 per share, for the same period in 2006.

As of September 30, 2007, CuraGen had cash and investments of $153.6 million. Of the available cash and investments, $14.4 million is classified as restricted cash until August 2008 and relates to funds held in escrow following the sale of CuraGen's ownership in 454 Life Sciences. At the end of the third quarter, CuraGen had outstanding convertible debt of $109.4 million, compared to $176.2 million at December 31, 2006.

During the third quarter, $9.7 million of cash and investments was used to support continuing operations, which excluded payments of approximately $1 million for severance and related benefits. Cash and investments used during the quarter was offset by proceeds of $2.8 million primarily from the sale of assets disposed of in connection with the previously announced closure of the BPS facility and $6.3 million from the sale of long-term marketable securities.

"We believe that CuraGen's cash position provides us with the resources and flexibility to advance our products through value-creating milestones and potentially bring them to market," commented Dr. Timothy Shannon, President and Chief Executive Officer of CuraGen. "We continue to focus our clinical development efforts on belinostat, our HDAC inhibitor that is currently in a broad Phase II program exploring mu
'/>"/>

SOURCE CuraGen Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Autopsy reports could be valuable and informative
2. China reports declining number of SARS Cases
3. Russia Reports First SARS Case
4. Research reports that c-section deliveries are rising
5. Jharkhand reports 13,000 Malaria cases
6. Uganda Reports Failure To Contain Sleeping Sickness
7. WHO reports 36 million deaths world wide due to chronic diseases
8. Reports of Hantavirus infection in India raise concerns
9. Controversy Surrounding The HIV Positive Reports Of One-Year Girl In Kerala
10. China Reports Yet Another Bird Flu Case
11. China reports seventh bird flu victim
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2014)... Los Angeles, CA (PRWEB) November 27, 2014 ... are thrilled to be part of Omadox, a feature ... Film Festival, including an award for best ensemble cast. It ... Festival. This is a great start to a successful cinematic ... experimental/sci-fi, black and white movies. If you enjoy experimental mystery, ...
(Date:11/27/2014)... Acapulco, Guerrero (PRWEB) November 27, 2014 ... the time individuals allot to sleep has lessened, ... televisions and laptops, the quality of sleep has ... workers falls asleep on the job (Reference: ... American worker’s productivity index by an incalculable amount, ...
(Date:11/27/2014)... An inventor from Buffalo, N.Y., knows that ... and she wants to lessen its impact. "After showering ... that there needed to be a way to maintain ... use and producible in design variations, the End Scentuous ... throughout the day. It avoids bad odors, as well ...
(Date:11/27/2014)... York, New York (PRWEB) November 27, 2014 ... ) have been filed in a consolidated ... Liebhard LLP reports. , Documents recently updated ... 1,079 records included in the state proceeding, all ... schizophrenia, bipolar disorder and other psychiatric conditions. Many ...
(Date:11/27/2014)... -- Most babies and young children don,t need medicines ... Drug Administration says. Over-the-counter (OTC) cold and cough ... 2 because they could cause serious and potentially deadly ... about three colds a year, but children get them ... want to give them pain relievers, decongestants and other ...
Breaking Medicine News(10 mins):Health News:Luciana Lagana and Gregory Graham Join the Award-Winning Cast of the Black-and-White Experimental Mystery Feature Film Omadox. 2Health News:Luciana Lagana and Gregory Graham Join the Award-Winning Cast of the Black-and-White Experimental Mystery Feature Film Omadox. 3Health News:Research Shows Surprising Number of US Workers Affected by Lack of Sleep 2Health News:New Risperdal Lawsuits Added to Philadelphia Litigation, Bernstein Liebhard LLP Reports 2Health News:New Risperdal Lawsuits Added to Philadelphia Litigation, Bernstein Liebhard LLP Reports 3Health News:New Risperdal Lawsuits Added to Philadelphia Litigation, Bernstein Liebhard LLP Reports 4Health News:Steer Clear of Cold Meds for Babies, FDA Advises 2
... The European Molecular Biology Organization (EMBO) today ... 63 life scientists from 14 countries. The researchers ... joining almost 1500 of the world,s leading molecular ... the organization,s international reputation and our most valuable ...
... , TUESDAY, Oct. 26 (HealthDay News) --Middle-aged ... cancer as a result of radiation exposure as younger ... are thought to be more sensitive to the long-term ... observation runs counter to some previous research suggesting that ...
... Reporter , TUESDAY, Oct. 26 (HealthDay News) -- People with ... may be at increased risk for serious complications after coronary ... variants seems to reduce the effectiveness of Plavix and put ... stent, suffering a heart attack or stroke, or even dying, ...
... Reporter , TUESDAY, Oct. 26 (HealthDay News) -- New research ... in patients with a certain genetic mutation. While guidelines ... mutations in their KRAS gene should not receive ... a subset of these patients might actually benefit from taking ...
... , TUESDAY, Oct. 26 (HealthDay News) -- Older adults ... physical limitations and problems with mental functioning, a new study ... nursing homes and puts an increased burden on caregivers and ... death among the elderly, the researchers said. Also called ...
... known as juvenile diabetes, is a multifactorial disease ... of pancreatic beta cells. In addition to genetic ... play important roles in triggering disease, with virus ... infections including cytomegalovirus, mumps, rubella, enteroviruses, and parvovirus ...
Cached Medicine News:Health News:EMBO recognizes 63 researchers for advances in life sciences 2Health News:EMBO recognizes 63 researchers for advances in life sciences 3Health News:Cancer Risk From Radiation Doesn't Fade With Age 2Health News:Gene Mutations May Blunt Plavix's Effectiveness, Study Finds 2Health News:Gene Mutations May Blunt Plavix's Effectiveness, Study Finds 3Health News:New Insights on Who Should Take Erbitux for Colon Cancer 2Health News:Brain Deficits Higher in Seniors Who Survive Blood Poisoning 2Health News:Haptoglobin as an early serum biomarker of virus-induced type 1 diabetes in rats 2
(Date:11/26/2014)... Nov. 25, 2014 Reinforcing its commitment to ... (NYSE: PHG AEX: PHIA) today announced ... (FDA) for its IQon Spectral CT , presenting ... kind technology adds a new dimension to Computed Tomography ... to characterize structures based on their material content within ...
(Date:11/26/2014)... , Nov. 25, 2014   Heska Corporation (NASDAQ: ... the "Company"), a provider of advanced veterinary diagnostic and ... Grieve , Executive Chair, will attend The Benchmark Company, LLC,s ... one-on-one conference will be held at The Palmer House Hilton, ... from 8 a.m. to 2:30 p.m. Please email hska@haydenir.com ...
(Date:11/26/2014)... , Nov. 25, 2014  Breckenridge Pharmaceutical, Inc. ... multi-product ANDA agreement with Pii (Pharmaceutics International, Inc.) ... which Breckenridge and Pii expect to develop and ... the agreement, Pii will develop, manufacture and supply ... the products under its own label.  The drugs, ...
Breaking Medicine Technology:Philips receives FDA 510(k) clearance for IQon Spectral CT 2Philips receives FDA 510(k) clearance for IQon Spectral CT 3Heska to Attend Benchmark Micro Cap Discovery Conference 2Breckenridge Pharmaceutical signs Multi-Product Generic Agreement with Pharmaceutics International, Inc. 2
... Oct. 7 Curemark, LLC, a drug research and ... announced the promotions of two senior executives. Dr. ... operations, and Matthew Heil, Ph.D., senior vice president of ... company. , Zinberg oversees day-to-day management of Curemark and ...
... 7 Rib-X Pharmaceuticals, Inc., a company focused on ... the treatment of multi-antibiotic resistant infections, today announced that ... Sterling Professor of Molecular Biophysics and Biochemistry at Yale ... A. Steitz, Ph.D., has been awarded the Nobel Prize ...
Cached Medicine Technology:Curemark Announces Senior Executive Promotions 2Curemark Announces Senior Executive Promotions 3Rib-X Pharmaceuticals, Inc. Co-Founder, Thomas A. Steitz, Ph.D., Awarded the 2009 Nobel Prize in Chemistry 2Rib-X Pharmaceuticals, Inc. Co-Founder, Thomas A. Steitz, Ph.D., Awarded the 2009 Nobel Prize in Chemistry 3Rib-X Pharmaceuticals, Inc. Co-Founder, Thomas A. Steitz, Ph.D., Awarded the 2009 Nobel Prize in Chemistry 4
Wright-Giemsa Stain Solutions...
... For fast, single-solution staining, Hema-Quik ... slides into stain solution for ... to deionized water for five ... second time by dipping quickly ...
... for staining of peripheral blood smears ... stain formulations still in use today. ... of Giemsa stain, although eosinophillic granules ... granules and nuclear chromatin stain a ...
This stain is the McNeal formula and can be substituted for Wright Stain solution....
Medicine Products: